⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1602931 | 0.95 | — | — | |
| SCHEMBL1603096 | 0.95 | — | — | |
| SCHEMBL1603958 | 0.95 | — | — | |
| SCHEMBL1603317 | 0.95 | — | — | |
| SCHEMBL1603253 | 0.95 | — | — | |
| SCHEMBL1603043 | 0.95 | — | — | |
| Hydrochloric Acid SCHEMBL6227562 | 0.93 | — | — | |
| SCHEMBL28588399 | 0.79 | — | — | |
| SCHEMBL466965 | 0.79 | — | — | |
| SCHEMBL5141266 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11078220-B2 | High-purity large-scale preparation of stannsoporfin | Mallinckrodt Hospital Products IP Limited (IE) | 2021-08-03 | — | — | US | disclosed |
| US-20200255458-A1 | HIGH-PURITY LARGE-SCALE PREPARATION OF STANNSOPORFIN | MALLINCKRODT LLC | 2020-08-13 | — | — | US | disclosed |
| US-10662209-B2 | High-purity large-scale preparation of stannsoporfin | Mallinckrodt Hospital Products IP Limited (IE) | 2020-05-26 | — | — | US | disclosed |
| US-20190202846-A1 | HIGH-PURITY LARGE-SCALE PREPARATION OF STANNSOPORFIN | SpecGx LLC | 2019-07-04 | — | — | US | disclosed |
| US-10273255-B2 | High-purity large-scale preparation of stannsoporfin | INFACARE PHARMACEUTICAL CORPORATION (US) | 2019-04-30 | — | — | US | disclosed |
| CN-104116745-B | composition comprising stannsoporfin | 婴儿护理药品公司 | 2018-07-06 | — | — | CN | disclosed |
| US-20180134735-A1 | HIGH-PURITY LARGE-SCALE PREPARATION OF STANNSOPORFIN | MALLINCKRODT LLC | 2018-05-17 | — | — | US | disclosed |
| US-9902745-B2 | High-purity large-scale preparation of stannsoporfin | INFACARE PHARMACEUTICAL CORPORATION (US) | 2018-02-27 | — | — | US | disclosed |
| US-20170073362-A1 | HIGH-PURITY LARGE-SCALE PREPARATION OF STANNSOPORFIN | VTESSE LLC | 2017-03-16 | — | — | US | disclosed |
| US-9517239-B2 | High-purity large-scale preparation of stannsoporfin | INFACARE PHARMACEUTICAL CORPORATION (US) | 2016-12-13 | — | — | US | disclosed |
| US-20150051184-A1 | HIGH-PURITY LARGE-SCALE PREPARATION OF STANNSOPORFIN | SUCAMPO PHARMA AMERICAS LLC | 2015-02-19 | — | — | US | disclosed |
| CN-104116745-A | Compositions comprising stannsoporfin | INFACARE PHARMACEUTICAL CORP | 2014-10-29 | — | — | CN | disclosed |
| US-8835416-B2 | High-purity large-scale preparation of stannsoporfin | INFACARE PHARMACEUTICAL CORPORATION (US) | 2014-09-16 | — | — | US | disclosed |
| US-20140005380-A1 | HIGH-PURITY LARGE-SCALE PREPARATION OF STANNSOPORFIN | INFACARE PHARMACEUTICAL CORPORATION (US) | 2014-01-02 | — | — | US | disclosed |
| US-8530458-B2 | High-purity large-scale preparation of stannsoporfin | INFACARE PHARMACEUTICAL CORPORATION (US) | 2013-09-10 | — | — | US | disclosed |
| EP-2384756-A2 | High-purity large-scale preparation of stannsoporfin | InfaCare Pharmaceutical Corporation (US) | 2011-11-09 | — | — | EP | disclosed |
| US-7960371-B2 | reduction of hemin with hydrogenation catalysts, in the presence of hydrogen, then heating to remove iron and form mesoporphyrin, and reacting with tin oxide top form pure tin mesoporphyrin; inhibitor of heme oxygenase, used in the treatment of infant jaundice or hyperbilirubinemia; liver disorders | INFACARE PHARMACEUTICAL CORPORATION (US) | 2011-06-14 | — | — | US | disclosed |
| US-20110082292-A1 | HIGH-PURITY LARGE-SCALE PREPARATION OF STANNSOPORFIN | OCERA THERAPEUTICS LLC | 2011-04-07 | — | — | US | disclosed |
| CN-101573122-A | High purity large scale preparation of stannsoporfin | INFACARE PHARMACEUTICAL CORP (US) | 2009-11-04 | — | — | CN | disclosed |
| US-20080125585-A1 | HIGH-PURITY LARGE-SCALE PREPARATION OF STANNSOPORFIN | STRATATECH CORPORATION | 2008-05-29 | — | — | US | disclosed |